Buscar centros médicos participantes y el estado actual del estudio en cada uno de ellos

    Buscar centros médicos participantes

    A clinical trial to look at how safe and effective atezolizumab plus nab-paclitaxel is for treatment of triple-negative breast cancer (TNBC) that cannot be removed with surgery

    A Study of Atezolizumab (Tecentriq) Plus Nab-Paclitaxel or Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic Triple‑Negative Breast Cancer

    • Cáncer
    • Cáncer de mama
    • Cáncer de mama triple negativo